Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT07383142
Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)
Surgery Combined With Hyperthermic Intrathoracic Chemotherapy Versus Surgery Alone for Pleural Dissemination or Pleural Recurrence of Thymic Epithelial Tumors: A Prospective, Multicenter, Randomized Controlled Clinical Trial
Sponsor: Fujian Medical University Union Hospital
Conditions
Thymic Epithelial Tumor
Interventions
Surgery alone Surgery+HITOC
Updated 1 time since 2026 Last updated: Feb 4, 2026 Started: Feb 1, 2026 Primary completion: Feb 1, 2029 Completion: Feb 1, 2032
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Thymic Epithelial Tumor, this trial is actively recruiting participants. The trial is conducted by Fujian Medical University Union Hospital and has accumulated 1 data snapshot since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Fujian Medical University Union Hospital
- Jiangxi Provincial People's Hopital
- Liaoning Cancer Hospital & Institute
- Qilu Hospital of Shandong University
- Shanghai Zhongshan Hospital
- Sir Run Run Shaw Hospital
- Tang-Du Hospital
- West China Hospital
- Xuhui Central Hospital, Shanghai
- Zhongshan Hospital (Xiamen), Fudan University
Data source: Shanghai Zhongshan Hospital
For direct contact, visit the study record on ClinicalTrials.gov .